Copyright
©The Author(s) 2022.
World J Clin Cases. Apr 26, 2022; 10(12): 3698-3708
Published online Apr 26, 2022. doi: 10.12998/wjcc.v10.i12.3698
Published online Apr 26, 2022. doi: 10.12998/wjcc.v10.i12.3698
Table 4 The comparison of clinical data between the observation and control groups, n (%)
Clinical data | Observation group (n = 60) | Control group (n = 58) | t/χ2 | P value |
Age (yr) | 54.49 ± 4.29 | 55.70 ± 5.10 | -1.396 | 0.165 |
BMI (kg/m2) | 22.02 ± 2.05 | 22.10 ± 2.54 | -0.189 | 0.851 |
Karnofsky score (points) | 74.40 ± 5.12 | 75.52 ± 6.02 | -1.090 | 0.278 |
Differentiation degree | 1.188 | 0.276 | ||
High differentiation | 23 (38.33) | 28 (48.28) | ||
Medium low differentiation | 37 (61.67) | 30 (51.72) | ||
Intravascular tumor thrombus | 0.337 | 0.562 | ||
Yes | 14 (23.33) | 11 (18.97) | ||
No | 46 (78.33) | 47 (81.03) | ||
Tumor size | 0.576 | 0.448 | ||
> 5 cm | 29 (48.33) | 24 (41.38) | ||
≤ 5 cm | 31 (51.67) | 34 (58.62) | ||
TNM stages | 0.009 | 0.926 | ||
III | 48 (80.00) | 46 (79.31) | ||
IV | 12 (20.00) | 12 (20.69) | ||
Pathological type | 0.735 | 0.391 | ||
Invasive ductal carcinoma | 47 (78.33) | 49 (84.48) | ||
Other | 13 (21.67) | 9 (15.52) | ||
KPNA2 expression | 0.016 | 0.899 | ||
Positive | 41 (68.33) | 39 (67.24) | ||
Negative | 19 (31.67) | 19 (32.76) | ||
SOX2 expression | 0.012 | 0.914 | ||
Positive | 45 (75.00) | 43 (74.14) | ||
Negative | 15 (25.00) | 15 (25.86) | ||
Ki-67 | 0.518 | 0.472 | ||
≤ 14% | 17 (28.33) | 20 (34.48) | ||
> 14% | 43 (71.67) | 38 (65.52) | ||
P53 | 0.210 | 0.647 | ||
Positive | 39 (65.00) | 40 (68.97) | ||
Negative | 21 (35.00) | 18 (31.03) |
- Citation: Ding F, Chen RY, Hou J, Guo J, Dong TY. Efficacy and prognostic factors of neoadjuvant chemotherapy for triple-negative breast cancer. World J Clin Cases 2022; 10(12): 3698-3708
- URL: https://www.wjgnet.com/2307-8960/full/v10/i12/3698.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i12.3698